Products Olumacostat Glasaretil Gel, 5.0%
Olumacostat Glasaretil Gel, 5.0% Phase 3 Completed 📈 Rising Mar 21, 2017 → Apr 27, 2018
About Olumacostat Glasaretil Gel, 5.0% Olumacostat Glasaretil Gel, 5.0% is a phase 3 stage product being developed by Eli Lilly for Acne Vulgaris. The current trial status is completed. This product is registered under clinical trial identifier NCT03127956. Target conditions include Acne Vulgaris.
Clinical Trials (3) NCT ID Phase Status Start Completion Indication NCT03127956 Phase 3 Completed Mar 21, 2017 Apr 27, 2018 Acne Vulgaris NCT03073486 Phase 3 Completed Feb 6, 2017 Dec 21, 2017 Acne Vulgaris NCT03028363 Phase 3 Completed Dec 27, 2016 Nov 28, 2017 Acne Vulgaris
Product Company Stage Hype Score HT-001 2% Topical Gel + HT-001 1% Topical Gel + HT-001 0.5% Topical Gel + HT-001 Placebo Hoth Therapeutics Phase 2 Trifarotene Cream 0.005% + AKLIEF® Cream (Trifarotene 0.005%) US REFERENCE LISTED DRUG + AKLIEF® Cream (Trifarotene 50 mcg/g) CANADIAN REFERENCE PRODUCT + Placebo Sun Pharmaceutical Phase 1 Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo Control Sun Pharmaceutical Phase 1 Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% + Acanya® Gel, 1.2%/2.5% + Vehicle of test product Sun Pharmaceutical Phase 1 Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + Duac® Topical Gel + Placebo Topical Gel Sun Pharmaceutical Phase 1 Adapalene Gel 0.1% + Placebo Control + Differin® Gel (Adapalene 0.1%, Galderma) Sun Pharmaceutical Phase 1 Trifarotene Cream 0.005% + Placebo + AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories) Sun Pharmaceutical Phase 1 Adapalene/BP gel, 0.3%/2.5% + EPIDUO® FORTE + Placebo Sun Pharmaceutical Phase 1 ADPS topical product + Placebo Control Sun Pharmaceutical Phase 2 Isotretinoin Sun Pharmaceutical Approved Winlevi (Clascoterone) cream 1% Sun Pharmaceutical Approved Adapalene Gel 0.3% + Differin® + Placebo Sun Pharmaceutical Phase 1 CLPG Topical Gel 1% + Clindamycin + Placebo Sun Pharmaceutical Phase 1 Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% + Epiduo® Gel + Placebo Sun Pharmaceutical Phase 1 Test. + Aczone Gel 5% + Placebo Sun Pharmaceutical Phase 1 Clindamycin and Benzoyl Peroxide Gel 1%5% + BenzaClin® Topical Gel + Placebo Sun Pharmaceutical Phase 1 Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% + Onexton™ Gel + Placebo Sun Pharmaceutical Phase 1 Clindamycin Phosphate + Clindamycin Phosphate RLD + Placebos Sun Pharmaceutical Phase 1 Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% + CABTREO Topical Gel + Placebo Control Sun Pharmaceutical Phase 1 Tretinoin cream, 0.05% + RETIN-A® (tretinoin) cream, 0.05% + Vehicle of the test product Sun Pharmaceutical Phase 1
Other Products from Eli Lilly